Literature DB >> 6132447

Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.

J L Waddington, A J Cross, S J Gamble, R C Bourne.   

Abstract

A syndrome of spontaneous orofacial dyskinesia was identified in groups of rats treated for 6 months with a wide range of neuroleptic drugs. Phenothiazines, thioxanthenes, and substituted benzamides were particularly likely to induce the syndrome. It was observed in the presence of a functional blockade of dopamine receptors and endured for at least 2.5 months after drug withdrawal. There was no relation between the syndrome and changes in striatal dopamine receptors, as indexed by the binding of tritiated spiperone and tritiated cis(Z)-flupenthixol. The syndrome parallels several of the features of clinical tardive dyskinesia, whose pathophysiology thus may not involve changes in the characteristics of striatal dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132447     DOI: 10.1126/science.6132447

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  53 in total

1.  Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.

Authors:  Ian E J De Souza; Niamh M Dawson; Jeremiah J Clifford; John L Waddington; Gloria E Meredith
Journal:  Psychopharmacology (Berl)       Date:  2003-06-27       Impact factor: 4.530

2.  Drug-induced oral dyskinesias in rats after traditional and new neuroleptics.

Authors:  T Kakigi; X M Gao; C A Tamminga
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.

Authors:  Jeroen P Koning; Jelle Vehof; Huibert Burger; Bob Wilffert; Asmar Al Hadithy; Behrooz Alizadeh; Peter N van Harten; Harold Snieder
Journal:  Psychopharmacology (Berl)       Date:  2011-07-13       Impact factor: 4.530

4.  Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats.

Authors:  O A Andreassen; T O Aamo; H A Jøorgensen
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 5.  Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

Authors:  J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.

Authors:  R E Steinpreis; P Baskin; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats.

Authors:  O A Andreassen; H A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

10.  Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.

Authors:  T Ashizawa; T Saito; N Takahata
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.